Learn about their journey through an interview with , co-founder and CEO of ! We are proud to support them at ViVe in Los Angeles and excited to see their impact on optimizing cancer care trajectories.
What motivated you and your other co-founders to start Gray Oncology?
A combination of experience and a desire to bring research into real, clinical environments. Three PhDs in medical physics have led to first-hand experience of the operational challenges in the radiation oncology space, along with the expertise from decades of operations research (from co-founders and Polytechnique professors Louis-Martin Rousseau and Nadia Lahrichi)
What are some challenges you are facing while scaling your start-up?
The operational challenges we are solving require highly disruptive solutions by nature in environments (healthcare institutions) that are fairly rigid, which means long sales cycles, change management, etc. Still, we've had great champions at our partner institutions who witnessed the operational challenges on a day-to-day basis, saw the potential of our solutions, and pushed it to deployment in their center.
How did the Dobson Centre play a role in Gray Oncology as we know it today?
The Dobson Centre has been supportive throughout our growth, ranging from mentorship to network introductions, supporting our travel, and facilitating numerous market exploration events.
Who would be an ideal partner or collaborator for Gray Oncology?
A healthcare institution aiming to optimize its oncology trajectories, specifically across radiation therapy and infusion therapy.
What are you most excited about for ViVe in Los Angeles?
We’re most excited to have the opportunity to meet numerous partners in LA, whether they’re healthcare institutions, investors, or other KOLs. Greater opportunity to engage with the ecosystem on the problems of both today and tomorrow.
About Gray Oncology
Gray is driven by a vision of a healthcare system where no resources are wasted. Founded in 2019 by a pair of PhDs in medical physics and their trio of professors, the company has created GrayOS, the operating system that automates, optimizes, and orchestrates the logistics of cancer care trajectories. GrayOS has now helped numerous North American cancer centers increase access to care while reducing costs and improving staff satisfaction.
